XenoPort, Inc.
Get verified emails for XenoPort, Inc. employees
About XenoPort, Inc.
|
|
|
51-200 employees
View all
|
|
Pharmaceuticals
|
|
United States
|
|
XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Horizant® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in the United States by XenoPort. Regnite® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in Japan by Astellas Pharma Inc. XenoPort holds all other world-wide rights to gabapentin enacarbil. XenoPort's pipeline of product candidates includes potential treatments for patients with Parkinson's disease, relapsing-remitting multiple sclerosis and psoriasis.
|
XenoPort, Inc. Email Format
The widely used XenoPort, Inc. email format is {first}.{last}@xenoport.com (e.g. [email protected]), which is used 75% of the time.
| XenoPort, Inc. Email Formats | Example Email Formats | Percentage |
|---|---|---|
| {first}.{last} | [email protected] |
75%
|
XenoPort, Inc. Alternatives
Frequently Asked Questions about XenoPort, Inc.
What is XenoPort, Inc. email format?
The widely used XenoPort, Inc. email format is {first}.{last} (e.g. [email protected]) with 75% adoption across the company.
What is XenoPort, Inc. customer service number?
To contact XenoPort, Inc. customer service number in your country click here to find.
XenoPort, Inc. Staff Directory
Search XenoPort, Inc. Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
